The consistency of neuropathological diagnoses in patients undergoing surgery for suspected recurrence of glioblastomaMatthias Holdhoff, Peter C. Burger, Xiaobu Ye et al.|Journal of Neuro-Oncology|2018Cited by 43
Optimizing eligibility criteria and clinical trial conduct to enhance clinical trial participation for primary brain tumor patientsEudocia Q. Lee, Patrick Y. Wen, Michael Weller et al.|Neuro-Oncology|2020Cited by 40
Re-irradiation for malignant glioma: Toward patient selection and defining treatment parameters for salvageColette J. Shen, Lawrence Kleinberg, Megan N. Kummerlowe et al.|Advances in Radiation Oncology|2018Cited by 37
Multimodal platform for assessing drug distribution and response in clinical trialsBegoña Giménez, Nathalie Y.R. Agar, Ishwar N. Kohale et al.|Neuro-Oncology|2021Cited by 14
A window-of-opportunity trial reveals mechanisms of response and resistance to navtemadlin in patients with recurrent glioblastomaVerónica Rendo, Rameen Beroukhim, Eudocia Q. Lee et al.|Science Translational Medicine|2025Cited by 13